Soluble TREM2 is elevated in Parkinson’s disease subgroups with increased CSF tau

Parkinson’s disease is the second most common neurodegenerative disease after Alzheimer’s disease and affects 1% of the population above 60 years old. Although Parkinson’s disease commonly manifests with motor symptoms, a majority of patients with Parkinson’s disease subsequently develop cognitive i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Brain
Egile Nagusiak: Wilson, Edward N, Swarovski, Michelle S, Linortner, Patricia, Shahid, Marian, Zuckerman, Abigail J, Wang, Qian, Channappa, Divya, Minhas, Paras S, Mhatre, Siddhita D, Plowey, Edward D, Quinn, Joseph F, Zabetian, Cyrus P, Tian, Lu, Longo, Frank M, Cholerton, Brenna, Montine, Thomas J, Poston, Kathleen L, Andreasson, Katrin I
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2020
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7089668/
https://ncbi.nlm.nih.gov/pubmed/32065223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/awaa021
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak